ArticleBriefings in bioinformatics2024
PartIES: a disease subtyping framework with Partition-level Integration using diffusion-Enhanced Similarities from multi-omics Data.
Article in Briefings in bioinformatics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- CSIE: cancer subtyping via inference and ensemble.Briefings in bioinformatics · 2026Article
- CEDR: robust consensus cancer subtyping with multi-omics data via ensemble dimensionality reduction.Briefings in bioinformatics · 2026Article
- SeOMLR: one-step multi-view latent representation with self-weighted ensemble learning for multi-omics cancer subtyping.Bioinformatics (Oxford, England) · 2026Article
- Advancing liver cancer diagnosis and treatment with multi-omics approaches: a systematic review.Discover oncology · 2025Review
- Artificial intelligence for comprehensive DNA methylation analysis: overview, challenges, and future directions.Briefings in bioinformatics · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Integrating multi-omics data helps identify disease subtypes. Many similarity-based methods were developed for disease subtyping using multi-omics data, with many of them focusing on extracting common clustering structures across multiple types of omics data, but not preserving data-type-specific clustering structures. Moreover, clustering performance of similarity-based methods is affected when similarity measures are noisy. Here we proposed PartIES, a Partition-level Integration using diffusion-Enhanced Similarities to perform disease subtyping using multi-omics data. PartIES uses diffusion to reduce noises in individual similarity/kernel matrices from individual omics data types first, and then extract partition information from diffusion-enhanced similarity matrices and integrate the partition-level similarity through a weighted average iteratively. Simulation studies showed that (1) the diffusion step enhances clustering accuracy, and (2) PartIES outperforms competing methods, particularly when omics data types provide different clustering structures. Using mRNA, long noncoding RNAs, microRNAs expression data, DNA methylation data, and somatic mutation data from The Cancer Genome Atlas project, PartIES identified subtypes in bladder urothelial carcinoma, liver hepatocellular carcinoma, and thyroid carcinoma that are most significantly associated with patient survival across all methods. Further investigations suggested that among subtype-associated genes, many of those that are highly interacting with other genes are known important cancer genes. The identified cancer subtypes also have different activity levels for some known cancer-related pathways. The R code can be accessed at https://github.com/yuqimiao/PartIES.git.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.